ARS PHARMACEUTICALS INC (SPRY) Institutional Ownership and Insiders Activity

ARS PHARMACEUTICALS INC (SPRY) is widely held by institutional investors, with 1 tracked firm reporting positions valued at approximately $8.03M based on SEC Form 13F filings for the quarter ended March 31, 2026.

Third Point is the largest disclosed holder, reporting approximately $8.03M in SPRY holdings in its latest filing.

Institutional ownership among tracked investors remains highly concentrated, with Third Point representing the majority of disclosed value.

Recent insider activity includes 2 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.